Single center real-world data on Letermovir prophylaxis for cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Derigs, P. [1 ]
Schubert, M. -L. [1 ]
Schnitzler, P. [2 ]
Mueller-Tidow, C. [1 ]
Dreger, P. [1 ]
Schmitt, M. [1 ]
机构：
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Hematol, Oncol,Rheumatol, Heidelberg, Germany
[2] Heidelberg Univ Hosp, Dept Virol, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V665
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [41] Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation
    Chen, Teaghan T.
    David, Alexandria P.
    Barthelmess, Erin K.
    MacBrayne, Christine E.
    PEDIATRIC BLOOD & CANCER, 2023,
  • [42] Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
    Kampouri, Eleftheria
    Zamora, Danniel
    Kiem, Erika S.
    Liu, Winnie
    Ibrahimi, Sarah
    Blazevic, Rachel L.
    Lovas, Erika A.
    Kimball, Louise E.
    Huang, Meei-Li
    Jerome, Keith R.
    Oshima, Masumi Ueda
    Mielcarek, Marco
    Zerr, Danielle M.
    Boeckh, Michael J.
    Krantz, Elizabeth M.
    Hill, Joshua A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (11) : 1450.e1 - 1450.e7
  • [43] Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
    Gill, Jessica
    Stella, Davide
    Dogliotti, Irene
    Dellacasa, Chiara
    Giaccone, Luisa
    Busca, Alessandro
    HEMATO, 2023, 4 (02): : 158 - 169
  • [44] Comment on: Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic cell transplantation
    Styczynski, Jan
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [45] Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation
    Koch, K.
    Herhaus, P.
    Osswald, L.
    Braitsch, K.
    Bassermann, F.
    Verbeek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 62 - 62
  • [46] Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
    Zhang, Shijia
    Shanley, Ryan
    Weisdorf, Daniel J.
    Rashidi, Armin
    BLOOD ADVANCES, 2020, 4 (12) : 2640 - 2643
  • [47] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
  • [48] Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation
    Kaur, Raena
    Purtill, Duncan
    Cooney, Julian
    Cannell, Paul
    Wright, Matthew
    Copeland, Tandy-Sue
    McGuire, Matthew
    Boan, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [49] Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation
    Kaur, Raena
    Purtill, Duncan
    Cooney, Julian
    Cannell, Paul
    Wright, Matthew
    Copeland, Tandy-Sue
    McGuire, Matthew
    Boan, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [50] A Single Center Retrospective Analysis of Letermovir for Cytomegalovirus Prophylaxis after Allogeneic Stem Cell Transplant in Cytomegalovirus Seropositive Recipients or Donors
    Liu, Lawrence
    Yn, Alicia
    Gao, Feng
    Olson, Marissa
    Crain, Mallory
    Schroeder, Mark A.
    BLOOD, 2021, 138
12345